Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
94
-
Total 13F shares, excl. options
-
33.9M
-
Shares change
-
+57.6K
-
Total reported value, excl. options
-
$235M
-
Value change
-
-$945K
-
Put/Call ratio
-
0.84
-
Number of buys
-
48
-
Number of sells
-
-45
-
Price
-
$6.93
Significant Holders of REGULUS THERAPEUTICS INC - COM (RGLS) as of Q1 2016
115 filings reported holding RGLS - REGULUS THERAPEUTICS INC - COM as of Q1 2016.
REGULUS THERAPEUTICS INC - COM (RGLS) has 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.9M shares
.
Largest 10 shareholders include FMR LLC (7.91M shares), WELLINGTON MANAGEMENT GROUP LLP (4.03M shares), Capital World Investors (3.54M shares), UBS ASSET MANAGEMENT AMERICAS INC (2.69M shares), Foresite Capital Management II, LLC (2.04M shares), BlackRock Fund Advisors (1.42M shares), VANGUARD GROUP INC (1.18M shares), RA CAPITAL MANAGEMENT, LLC (1.05M shares), AXA (894K shares), and Foresite Capital Management III, LLC (789K shares).
This table shows the top 94 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.